Overexpression of Bcl-xL Promotes Chemotherapy Resistance of Mammary Tumors in a Syngeneic Mouse Model
Authors:
- Carmen PageCPCarmen Page
- David R. BeidlerDBDavid R. Beidler
- Max S. WichaMWMax S. Wicha
- 1 December 1999
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (6) , 1861-1867
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Distinct Caspase Cascades Are Initiated in Receptor-mediated and Chemical-induced ApoptosisJournal of Biological Chemistry, 1999
- IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.1998
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase AktScience, 1997
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.Journal of Clinical Investigation, 1995
- The relationship between bcl‐2 expression and response to chemotherapy in acute leukaemiaBritish Journal of Haematology, 1994
- Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cellsBiochemical Pharmacology, 1994
- Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermiaBiochemical Pharmacology, 1990
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989